CMMB

Chemomab Therapeutics News

Company Name Stock Ticker Symbol Market Type
Chemomab Therapeutics Ltd CMMB NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.0001 0.0% 2.1999 10:29:48
Open Price Low Price High Price Close Price Prev Close
2.15 2.07 2.1999 2.20
more quote information »

Recent News

Date Time Source Heading
12/05/20227:15IHNWFeaturedElectromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022
11/30/202207:00PRNUSChemomab Announces Appointment of Mitchell L. Jones, MD, PhD..
11/18/202207:54EDGARStatement of Changes in Beneficial Ownership (4)
11/17/202216:57EDGARStatement of Changes in Beneficial Ownership (4)
11/16/202207:21EDGARCurrent Report Filing (8-k)
11/15/202216:04EDGARInitial Statement of Beneficial Ownership (3)
11/14/202216:11EDGARCurrent Report Filing (8-k)
11/11/202206:00PRNUSChemomab Therapeutics Announces Third Quarter 2022 Financial..
11/10/202216:13EDGARQuarterly Report (10-q)
11/09/202208:00PRNUSChemomab Presents Clinical Data from Investigator-Initiated..
11/01/202207:00PRNUSChemomab Therapeutics to Report Third Quarter 2022 Financial..
10/28/202207:00PRNUSChemomab Therapeutics to Present at Upcoming Scientific..
8/15/202216:07EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/12/202207:08EDGARCurrent Report Filing (8-k)
8/12/202206:00PRNUSChemomab Therapeutics Announces Second Quarter 2022..
8/01/202207:00PRNUSChemomab Therapeutics to Report Second Quarter 2022..
6/27/202208:00PRNUSChemomab Presents Data Further Supporting the Mechanism of..
6/21/202207:01EDGARCurrent Report Filing (8-k)
6/21/202207:00PRNUSChemomab Therapeutics Appoints Jill M. Quigley, JD, to Its..
6/09/202209:00PRNUSChemomab Therapeutics to Present at June Investor and..
6/08/202206:03EDGARCurrent Report Filing (8-k)
6/02/202207:00PRNUSData Supporting Role of Chemomab's Novel Therapeutic Target..
5/31/202210:31EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/25/202216:04EDGARStatement of Changes in Beneficial Ownership (4)
5/19/202216:03EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202207:00PRNUSChemomab Therapeutics to Participate in H.C. Wainwright..
5/12/202206:21EDGARCurrent Report Filing (8-k)
5/12/202206:00PRNUSChemomab Therapeutics Announces First Quarter 2022 Financial..
5/04/202207:00PRNUSChemomab Therapeutics to Report First Quarter 2022 Financial..
4/28/202216:07EDGARProxy Statement (definitive) (def 14a)
4/25/202216:20EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/23/202207:00PRNUSChemomab Therapeutics to Participate in Cantor Fitzgerald..
3/15/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
3/15/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
3/14/202216:21EDGARStatement of Changes in Beneficial Ownership (4)
3/14/202208:00PRNUSChemomab Reports on Two Scientific Presentations that..
3/09/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202216:04EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202216:02EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202206:03SEEKChemomab Therapeutics GAAP EPS of -$0.02 beats by $0.12
3/09/202206:00PRNUSChemomab Therapeutics Announces Fourth Quarter and Year End..
3/02/202208:00PRNUSChemomab Therapeutics to Report Fourth Quarter and Full Year..
2/11/202206:16EDGARCurrent Report Filing (8-k)
2/10/202208:00PRNUSChemomab Therapeutics to Present at Aegis Virtual Conference
1/04/202207:00PRNUSChemomab Therapeutics Names Jack Lawler Vice President of..
12/20/202108:00PRNUSChemomab to Participate in LifeSci Partners Annual Corporate..
12/16/202116:06EDGARCurrent Report Filing (8-k)
12/16/202116:05PRNUSChemomab Therapeutics Announces Expected Appointment of Dale..